Abstract | The effects of prenatal exposure to drugs on brain development are complex and are modulated by the timing, dose and route of drug exposure. It is difficult to assess these effects in clinical cohorts as these are beset with problems such as multiple exposures and difficulties in documenting use patterns. This can lead to misinterpretation of research findings by the general public, the media and policy makers, who may mistakenly assume that the legal status of a drug correlates with its biological impact on fetal brain development and long-term clinical outcomes. It is important to close the gap between what science tells us about the impact of prenatal drug exposure on the fetus and the mother and what we do programmatically with regard to at-risk populations.
Chemical neurotransmitters serve important functions in the coordination of the develop ment of neurons and brain circuits
. Psychoactive drugs modulate receptors, transporters and other components of neuro transmission, many of which are expressed during prenatal stages of brain development, although here their expression patterns and functions are sometimes quite different from their more typical roles later in life. Thus, the presence of these proteins in the developing brain underlies the welldocumented impact of prenatal drug exposure on brain architec ture, chemistry and neurobehavioural func tion in clinical cohorts and animal models.
Many legal drugs, such as nicotine and alcohol, can produce more severe deficien cies in brain development than some illicit drugs, such as cocaine. However, errone ous and biased interpretations of the sci entific literature often affect educational programmes and even legal proceedings. For example, a pregnant woman whose emergency room toxicology screen revealed cocaine use was recently jailed and accused of using a deadly weapon against her unborn child in Tennessee, United States 1 . Such pol icy decisions may have unintended adverse consequences: for example, they might harm the fetus through pathophysiological activa tion of the maternal stress response system 2 and they might cause pregnant women addicted to drugs to avoid prenatal medical care (BOX 2) .
The findings of research in humans and animal models should be used to inform better policy and programme development to reduce the population of children who are exposed to drugs prenatally. Much of the human data is being generated by the National Children's Study, which aims to examine the effects of environmental influ ences on the health and development of 100,000 children across the United States. However, logistical issues have made it diffi cult to coordinate and retain the participation of the mothers and children.
In this article, we describe findings from relevant animal models that illuminate the specific mechanisms by which drugs of abuse, both illegal and legal, affect brain development. It is not possible to adequately review all drugs and animal models owing to space limitations (see for other relevant reviews), therefore we have selected a few examples for which substantial data have been generated. We highlight clinical findings in humans that parallel many of the findings in model sys tems. Finally, we discuss the complex social and policy issues involved in providing appropriate support structures for children exposed to drugs in utero to help improve their neurodevelopmental trajectory.
Animal models of prenatal drug abuse
The utility of animal models for understand ing typical and atypical human development is well established. Animal models have enabled us to begin to elucidate the complex neurodevelopmental consequences of prena tal drug exposure. Although basic behaviour and some aspects of global structure and functional neural activity can be studied in humans exposed developmentally to drugs, the specific neuroanatomical, molecular and cellular consequences that underlie these behavioural changes are not accessible to study in vivo. Welldesigned animal models can therefore be powerful tools for revealing the neurobiological alterations that underlie later disrupted behaviour.
However, the challenges of developing appropriate animal models are substantial. For example, although the orderly assembly of the cellular elements that constitute the developing nervous system is highly con served across vertebrate species, the timing and duration of histogenic events and matu ration of neurotransmitter systems can dif fer substantially. Moreover, drug metabolic pathways differ depending on the route of exposure and across species; this therefore is another important variable in recapitulating drug exposure patterns in humans. There are several key experimental variables to be considered when designing an animal model . Because neurotransmitters appear well before synapses form, various roles in neurodevelopmental processes were postulated but not demonstrated. Modern in vitro approaches and genetic engineering of mice have facilitated discoveries that highlight the pleiotropic nature of neurotransmitter signalling in neurodevelopmental processes. To give a few examples of such non-synaptic functions, dopamine regulates progenitor cell cycle kinetics and dendritic growth 62, 193 , serotonin modulates cell proliferation and the response of growing axons to classic guidance molecules 149, 194 , GABA (γ-aminobutyric acid) activates the migration of developing neurons 195 and glutamate regulates oligodendrocyte precursor survival 196 . Key to these influences is the expression, in transient developmental patterns, of subsets of receptors that mediate early neurotransmitter signalling for developmental purposes. This is followed by spatial and temporal reorganization and by the expression of other subtypes that may be involved in modulating or directly inducing synaptic transmission.
of prenatal drug exposure: the age of the embryo during exposure, the species to be used, the frequency and duration of expo sure, the route of administration and the drug concentration.
The timeline for neurodevelopmental milestones has been documented in humans and for most animals used as models [7] [8] [9] ( FIG. 1) . Thus, designing animal models of drug exposure during particular stages of fetal animal development that correlate with the timing of exposure during human pregnancy is realistic, at least to a first approximation. There are, however, further complications when considering how to model human exposure. These include both nutritional issues and the use of two or more drugs in combination. In addition, provid ing an environment in which the mother feels comfortable in disclosing the length of exposure as well as the amounts and com binations of drugs used is crucial for deter mining clinical profiles and in subsequently using the data to establish accurate animal models. Furthermore, some processes that occur during the third trimester of in utero development in humans occur postnatally in rodents and thus might be missed by studies conducted during gestation only. Also, rodent maternal and environmental inter actions with the offspring are cru cial for their proper social and emotional development during this postnatal period, a situation that differs from that of humans during late gestation.
Different species can provide distinct advantages depending on the specific hypotheses to be tested. For example, if one wishes to investigate the roles of certain genes in mediating the impact of prenatal drug exposure, genetically engineered mice may be most appropriate. This might be weighed against the difficulties in admin istering drugs repeatedly to pregnant mice. Selfadministration drug paradigms during pregnancy may be more imitative of human abuse than experimenteradministered para digms, and rats have been the primary model species for this approach. on the other hand, establishing selfadministration in rodents is sometimes problematic and requires other reinforcers to be superimposed on drug administration. Nonhuman primates most closely model the temporal domains of human brain development and behaviour. However, it is logistically far more difficult and expensive to use nonhuman primates for research purposes, and as such this is not the ideal approach for rapid mechanistic discoveries. Many different models have been used throughout the long history of animal model research, and comparison of fundamental discoveries across species has been difficult. Cautious interpretation, in which one attempts to identify convergent findings, is particularly necessary for further advancements in the field. Convergence is often found in translating across larger behavioural dimensions, rather than in detailed features of the models.
Finally, patterns of administration of different drugs vary. Some drugs (such as cocaine) are typically used in discrete epi sodes, whereas others (such as nicotine and alcohol) tend to be used chronically. This issue is likely to be important in determining the effects of developmental drug exposures. Thus, the effects of various substances may be reflective of both their inherent neuro toxicity and the patterns with which they are (ab)used.
effects of illegal drugs of abuse Cocaine. Cocaine is a psychostimulant that binds to monoaminergic transporters (with a preference for dopaminergic transport ers) and prevents the uptake of extracel lular monoamines into the presynaptic cell. This results in excess neurotransmitter in the synaptic cleft and excess stimulation of dopamine receptors. There are five known dopamine receptors, which can be divided into two groups: D1like receptors (D1 and D5), and D2like receptors (D2, D3 and D4). The roles of dopamine and these receptors in reward pathways have been demonstrated in both humans and animal models 10, 11 . Dopamine receptors are also located in the prefrontal cortex, the hypothalamus, the brainstem and even outside the CNS [12] [13] [14] [15] . The dopamine system develops early in gestation in all vertebrate species, and might therefore be sensitive to exogenous manipu lation early in gestation. In fact, some early reports suggested a severe phenotype in children exposed to cocaine in utero [16] [17] [18] . Children were thought to be emotionally disrupted, cognitively impaired, less likely to socially interact, and more likely to die from sudden infant death syndrome. Thus, the term 'crack baby' was introduced to describe children exposed to cocaine prenatally. However, these original studies were con founded by very small sample sizes, use of multiple drugs, nutritional status and other psychosocial problems.
We now know that, irrespective of spe cies, the extent to which prenatal exposure to cocaine affects brain development var ies significantly. The assumptions made by the public about the biological impact of prenatal cocaine exposure may be based on the severity of symptoms associated with cocaine addiction, and the illegal nature of the substance. In humans, longitudinal studies have shown that there are longterm consequences of prenatal cocaine exposure; Box 2 | criminal prosecution of pregnant women using drugs of abuse A study in 1985 reporting damaging effects of cocaine use during pregnancy 16 produced a massive media response. Based on the media reports, laws were enacted in the United States requiring health-care professionals to report pregnant illicit drug users to child-welfare authorities, and legislation was pursued to make drug use during pregnancy a criminal offence. The desire to guard fetal health and outcomes is understandable; however, research shows that pregnant women who fear prosecution and the potential loss of their children as a result of using drugs of abuse are less likely to seek essential prenatal and medical care. Thus, the policies that were meant to deter illegal drug use among pregnant women had unintended consequences, resulting in even greater risk to the fetus 197, 198 . Moreover, the threat of criminal punishment can foster fear and mistrust between doctors and their patients, increase maternal stress and endanger the health of women and their future children. Based on the science, one could argue that this is considerably worse than the drug exposure itself.
South Carolina in the United States has been particularly aggressive in using the court system in an attempt to deter drug use during pregnancy. At least 90 women have been prosecuted for stillbirths after using drugs or alcohol. Between 1989 and 1994, a prominent hospital in Charleston adopted a policy of informing police of any positive test for cocaine in pregnant women. The patients were informed that an arrest would occur if they failed to successfully complete a drug programme. If a positive test was obtained at delivery the woman would be immediately arrested and charged 199 . This policy was discontinued in 1994 because of pressures applied by the Department of Health and Human Services 199 . It is not yet known whether she will be re-tried for the charge, but these events suggest that policy may be coming into better accordance with scientific data. Nature Reviews | Neuroscience however, the behavioural dysfunction seems to be mild [19] [20] [21] [22] [23] [24] . The recreational use of cocaine during pregnancy results in a subtle, although dominant, developmental pheno type that resembles attentiondeficit hyper activity disorder [19] [20] [21] [22] [25] [26] [27] [28] [29] . Detailed studies have shown that prenatal cocaine exposure can have longlasting negative effects on cognitive and attention systems, which are mediated by regions such as the prefrontal cortex and other higherorder cortical areas that express dopamine receptors and receive rich dopaminergic projections from the midbrain 19, 24, 27, [30] [31] [32] (TABLE 1) . recent data also suggest that there is increased likelihood that children exposed to cocaine prenatally will require special needs programmes 33 ; this, from both an individual and a societal perspective, is expensive.
Animal models confirm that prenatal cocaine exposure results in specific perma nent behavioural, cellular and molecular changes [34] [35] [36] [37] . An intravenous model of prenatal cocaine exposure in the rabbit closely models the human pharmacokinetic profile [38] [39] [40] . It has been used to delineate a number of highly specific changes, including altered GABA (γaminobutyric acid) levels in the cortex, altered expression of Ca 2+ binding proteins, morphological changes in pyrami dal cells and decreased dopamine D 1 receptor coupling to its cognate G protein, G s α [41] [42] [43] [44] [45] [46] (TABLE 1). The most surprising alteration was a permanent reduction in secondmessenger coupling, which was found to be due to abnormal internalization of the D 1 receptor. This suggested that the D 1 receptor is not trafficked properly to the cell membrane, where it interacts with G s α 47 . These cellu lar and molecular findings were observed only in dopaminerich cortical areas, which are intimately involved in cognition and executivefunctioning tasks, including atten tion [48] [49] [50] [51] [52] [53] . These studies have also been able to directly relate the timing of in utero cocaine exposure to its deleterious effects in offspring and suggest that the second trimester may be a particularly vulnerable period 54 . other animal models show that prenatal cocaine exposure alters basic processes of neocortical development, including cell pro duction and migration [55] [56] [57] [58] [59] [60] . These findings are consistent with recent studies demon strating that dopamine can regulate progeni tor cell proliferation and neuronal migration during prenatal development 61, 62 . Behavioural changes in response to cocaine exposure have been reported in various animal models. These include deficits in attention tasks and emotional reactivity as well as reductions in the rein forcing properties of drugs of abuse [30] [31] [32] 63, 64 . These findings correspond with the human clinical literature, which reports distur bances in both attention and emotion regulation in children exposed prenatally to cocaine.
Amphetamine and methamphetamine.
Amphetamine and methamphetamine are also psychostimulants; however, they target the monoaminergic system in a Figure 1 | Developmental events and ontogeny of drug targets. The peak periods of key neurodevelopmental events are depicted. Reference to the timing of neurotransmitter system development includes the appearance of receptors, transporters and synthetic machinery. Note that some of these neurotransmitter elements may continue to mature through puberty. Gestational age for both human and mouse are aligned with the arrow to define the timeline for these events. Emerging drug targets (receptors, transporters and so on) are depicted along this same timeline. 5-HT, 5-hydroxytryptamine (serotonin); Aff, afferents; CP, cortical plate; CTX, cortex; DA, dopamine; E, embryonic day; GABA, γ-aminobutyric acid; GE, ganglionic eminence; LC, locus coeruleus; M, months; MZ, marginal zone; NA, noradrenaline; P, postnatal day; PZ, proliferative zone; SP, subplate; VTA, ventral tegmental area; W, weeks. mechanistically distinct fashion from cocaine. Both drugs reverse the actions of monoamine transporters and enhance the release of dopamine, noradrenaline and serotonin in the synaptic cleft, increasing their availability to act on postsynaptic receptors. In addition, both drugs can block the reuptake and degradation of these neurotransmitters, further increas ing their concentrations in the synaptic cleft. The addition of a methyl group allows methamphetamine to move through lipid permeable membranes more easily than amphetamine. Both amphetamine and methamphetamine are routinely ingested, snorted and smoked. The frequency of use and abuse of amphetamine and metham phetamine has steadily risen in the human population, exceeding cocaine use in many regions of the United States 65 . Because methamphetamine and amphet amine use during pregnancy has become prolific only recently, there are few stud ies defining its longterm consequences. Children exposed to methamphetamine or amphetamine during prenatal development show decreased arousal, increased stress, decreased scholastic achievement, move ment disturbances and low birth weight (a highrisk factor for special needs pro grammes at school age) [66] [67] [68] [69] [70] . Neurocognitive testing showed that these children score lower on sustainedattention, longterm spatial and verbal memory, and visual motorintegration tests 71 . Neuroimaging has produced reports of smaller striatum and hippocampus volumes and decreased numbers of dopamine D 2 receptors and dopamine transporters 71, 72 . Use of multiple drugs and other psychosocial risks compli cate these studies 70, 73 , making it challenging to define the clinical impact of each drug indi vidually. rat and mouse models have helped delineate the specific neurodevelopmental consequences of prenatal amphetamine and methamphetamine exposure.
Animals exposed to methamphetamine have lower birth weights, increased inci dence of microgyria (smaller and more numerous convolutions in the cerebral cortex than usual) and deficits in visual system development [74] [75] [76] . They also display impaired postural motor movements, defi cits in specific learning paradigms, increased startle reflexes and decreased prepulse inhibition 76, 77 . Furthermore, alterations in the levels and activities of the noradren ergic and serotonergic systems have been demonstrated in animals exposed to either amphetamine or methamphetamine [78] [79] [80] . Some of the functional consequences (such as impaired sensorymotor coordination) of prenatal methamphetamine exposure are transmitted to the next generation of offspring 81 . These findings demonstrate that prenatal amphetamine or methamphetamine exposure leads to a complex behavioural phenotype with similarly complex molecular and cellular roots.
effects of legal drugs of abuse Nicotine. Nicotine binds to nicotinic acetyl choline receptors (nAChrs), ligandgated ion channels that are widely expressed throughout the fetal nervous system. Nicotine is usually presented to the fetus through maternal smoking or environmental exposure to secondhand smoke. research has provided unequivocal evidence that both can be teratogenic (for a review, see REF. 82 ), can lead to decreased birth weight and can increase the risks of preterm birth (TABLE 1) , all of which are highrisk fac tors for behavioural impairment 69, [83] [84] [85] . Furthermore, smoking is linked to an increased risk of sudden infant death syn drome. Numerous studies support a robust relationship between developmental tobacco smoke exposure and attentiondeficit dis orders, hyperactivity, antisocial behaviour and learning disabilities [86] [87] [88] [89] [90] [91] [92] [93] [94] . However, dif ferences in the amount of nicotine and other chemicals in different tobacco products make it challenging to compare findings across ethnic or age groups. Furthermore, the presence of additional potential neuro toxicants and biomodulators in tobacco smoke makes it difficult to determine the specific effects of nicotine exposure. This presents a challenge for clinicians who may wish to recommend nicotinereplacement therapy (NrT) to pregnant patients who have difficulty terminating smoking. Although the additional chemicals are absent in NrT, high amounts of nicotine are still presented to the fetus. Based on animal studies (see below), such exposure is likely to lead to longterm disruption of brain architecture and chemistry. In fact, transder malpatch NrT may actually worsen birth outcomes relative to active smoking 95, 96 . one possibility, as reviewed recently 97, 98 , is that this may be a result of the continuous deliv ery provided by the patch, which in animal models has been shown to cause fetal brain nicotine levels to reach up to three times those of maternal blood levels 99 . Animal studies have provided the most compelling evidence that nicotine has a substantial negative effect on neuro development. Activation of nAChrs affects morphogenesis, spontaneous neural activ ity and neuronal survival in rodents 100 . In animals, plasma nicotine levels similar to those of pregnant women smoking "moderate" numbers of cigarettes produce potent neuro behavioural effects -includ ing changes in locomotor activity, reward systems, anxiety and cognition -in off spring [100] [101] [102] [103] [104] [105] . Higher doses produce fetal hypoxia and substantial growth retarda tion 106 . Cortical cholinergic systems modu late sensory cognitive processing 107 , and prenatal nicotine exposure impairs cognitive functions in animal models and in chil dren 100, 108 . Intriguingly, nicotine inhibits aromatase, an enzyme involved in oestrogen synthesis in the placenta 109 ; this may inter fere with sexual differentiation of the brain in males, and changes have been observed in the timing of puberty onset in gestation ally exposed male adolescents 110 . Based on these findings, reducing smoking by preg nant women and their immediate family members will be very beneficial, whereas the value of NrT in pregnant women is ques tionable and requires indepth evaluation through prospective studies 98 .
Alcohol. Alcohol use spans all socioeconomic classes, gender, race, education and cultural groups. It is a pharmacological depressant, blocking NMDA (Nmethyldaspartate) receptor activity and increasing GABAergic activity, thereby decreasing cortical and sub cortical activity 111, 112 . Alcohol can also disrupt growth factor receptor signalling by disrupt ing plasma membrane integrity 113, 114 . GABA and its receptors are present early in neuronal development, and can modulate progenitor cell proliferation, cell migration and neurite growth [115] [116] [117] . Alcohol crosses the placental barrier at any point during pregnancy and thus can have a severe impact on numerous histogenic processes (see below and TABLE 1).
There is overwhelming basic and clinical evidence regarding the negative neurodevel opmental consequences of prenatal alcohol exposure. These constitute a disorder rec ognized by the International Classification of Diseases and the Diagnostic and Statistical Manual of Mental Disorders, fetal alcohol syndrome, which is characterized by growth deficiencies, craniofacial dysmorphologies and CNS damage 3, [118] [119] [120] [121] . Prenatal alcohol exposure can cause intellectual disability, deficits in learning, attention and motor development, and hyperactivity 119, 120, [122] [123] [124] [125] . Although concomitant use of other drugs with alcohol is not unusual, alcohol is often used as a solitary drug. This clinical population provides a less mechanistically complex picture of the neurodevelopmental consequences of prenatal alcohol exposure.
In addition, animal models have provided further understanding of the cellular and molecular consequences of prenatal ethanol exposure.
Animal models of prenatal ethanol exposure have confirmed an increase in birth defects, including neurological dys function 3, [126] [127] [128] [129] [130] . exposure during all ges tational periods has dramatic teratogenic consequences [131] [132] [133] . There are reports of a decrease in spinal and cranial motor neuron production and size, neocortical and hip pocampal dysgenesis, increased neuronal cell death, reduced or delayed neuronal migration and decreased myelination [134] [135] [136] [137] . ethanol exposure also disrupts the integrity of plasma membrane receptors 138, 139 . Thus, in addition to direct antagonism of neurotrans mitter receptors, receptor tyrosine kinase signalling is disrupted, leading to altered modulation of multiple histogenic events by neurotrophic factors.
elegant studies have begun to prove the impact of prenatal alcohol on endocrine function 140, 141 . As well as alcohol's direct effects on the fetus, it also acts directly on the hypothalamicpituitaryadrenal (HPA) axis of both the fetus and the mother. Modulating the HPA axis during develop ment can permanently alter its responsive ness to later stressors, setting off a cascade of behavioural, cognitive, and cellular altera tions in the adult 142 . Similarly, alterations in maternal HPA activity could underlie some of the longlasting consequences of prenatal alcohol exposure. As such, intervention and behavioural therapy for these children should perhaps include methods used in clinical populations of children exposed to severe stress in utero.
effects of prescription neurotherapeutics Antidepressant medications. A report of a higher rate of cardiac abnormalities in the children of women using selective serotonin reuptake inhibitors during pregnancy 143, 144 has led to enormous public and scientific interest. Animal studies have long implicated serotonin, the target of many antidepres sants, in the development of the brain and peripheral organs [145] [146] [147] . Serotonin and its receptors are expressed in the brain early in prenatal development 12, [148] [149] [150] [151] and can modify dendritic and axonal differentiation 149, 152 ( FIG. 1) . Although the mechanism remains unknown, early postnatal disruption of serotonin signalling in the rodent (at stages roughly equivalent to third trimester and neonatal human periods) can permanently increase anxiety behaviours and disrupt learning 153, 154 .
The animal studies are compelling, but epidemiological studies to date do not provide evidence of an increased risk of birth defects following use of selective serotonin reuptake inhibitors during preg nancy [155] [156] [157] [158] [159] . It is important to consider that, even though the rate of overt birth defects does not increase at typical doses, subtle yet significant behavioural dysfunctions in offspring could occur (similar to the situa tion with prenatal cocaine exposure). The issues are thus complex and require addi tional, detailed studies to inform medical decisions. Healthcare professionals must weigh the relative neurodevelopmental impact of drug treatment of a psychiatric disorder against the potentially negative outcomes of untreated illnesses (including increased maternal stress due to depression or neurochemical imbalances). Thus, when behavioural therapy alone is not effective in treating depression in a pregnant woman, the potential risk of drug therapy must be weighed against the risk for relapse of the disorder if pharmacological therapy is interrupted.
Other prescription medications. Several prescription medications are used for the treatment of psychiatric, neurological and maternal pregnancy disorders. little research has examined the longterm func tional implications of these drug treatments, but new studies are beginning to highlight a complex clinical picture.
Concerns have been raised regarding the effects of antipsychotic medications (potent antagonists of dopamine and serotonin receptors) taken during pregnancy. Animal studies point to serious potential neuro developmental risks [160] [161] [162] [163] [164] . However, there have been few clinical studies 165, 166 , making it difficult to draw accurate conclusions regarding longterm impact on fetal devel opment. As with other psychoactive drugs, an individualized calculation of relative risk is important to balance the potential risk of drug exposure against the risk of a potential psychotic episode if pharmacotherapy is suspended.
Another commonly prescribed drug is valproate, an anticonvulsant and anti mania therapeutic that blocks voltage gated Na + and Ttype Ca 2+ channels and inhibits the transamination of GABA 167 . As a histone deacetylase inhibitor, valproate can also regulate the epigenetic modula tion of gene transcription 168 . Clinical data demonstrate an increased risk for autism spectrum disorder as well as teratogenic (neural tube defects and craniofacial dysmorphia) and neurotoxic (apoptosis and reduced cell proliferation in multiple brain areas) effects in individuals exposed to val proate 169, 170 . rats exposed prenatally have lower sensitivity to pain, increased repeti tive or stereotypiclike activity, higher anxiety, decreased social interaction and an increased basal level of corticosterone 171, 172 . Alterations in NMDA receptor expression, enhanced longterm potentiation and neo cortical hyperconnectivity have also been reported 173, 174 . Terbutaline and other related drugs were previously commonly used in lateterm pregnancies to reduce premature uterine contractions by stimulating the β 2 adrenergic receptor 175 . exposure of neonatal animals to terbutaline results in neuroinflammation and longlasting behavioural and cellular deficits [176] [177] [178] . Furthermore, children exposed to terbutaline or related adrenoceptor stimulants during late gestation may have an increased incidence of learning and neuro psychiatric disorders 179, 180 . recent clinical studies have revealed an increased risk for the development of autism spectrum dis order in exposed offspring, consistent with a report of a modest increase in risk due to an allelic variant in the gene encoding the β 2 adrenergic receptor 181 ; whether this genetic predisposition and environmental risk interact with one another is not yet known. In fact, the efficacy of these drugs in preventing preterm delivery when used for maintenance tocolysis is suspect 182 , and their recognition for such uses has been withdrawn.
Balancing prenatal drug exposure
Basic and clinical research unequivocally demonstrate that recreational or prescription use of drugs during pregnancy negatively affects healthy development. There is a clear conundrum, however, with regard to the need to balance exposure (in a clinically prescribed population) with nonexposure when considering the longterm functional impact on brain development. The difficul ties relate to the fact that high prenatal stress, malnutrition and untreated maternal psychi atric disorders can themselves increase risk for developmental disabilities in children.
With regard to recreational drugs, human addictive behaviour makes this issue far more complicated than a simple public policy approach of 'just say no' . Furthermore, it is clear that the idea that illegal drugs are more harmful to the unborn fetus than legal drugs is incorrect; this concept, which strongly influences public policy, is not sup ported by findings from carefully designed and controlled research studies. For pregnant women who abuse drugs before conception, withdrawal of these drugs postconception is not without risk to the fetus. Maternal stress can be severe during withdrawal, and general health status may decline -both severely affecting the brain development of the fetus.
We now realize that prescription drug treatments for pregnant women with psy chiatric and neurological disorders can have negative effects on fetal brain develop ment and longterm behavioural outcomes. However, the underlying maternal patho physiology of untreated disorders can lead to highrisk nutritional and stress status for both the mother and the fetus. Perhaps underscoring the level of complexity of the maternal-fetal relationship, balancing these issues makes formulation of public and medical policies less straightforward than generally appreciated.
Proposals to reduce bias When considering particular conditions or states, people generally default to frames that are most familiar to them. Frames are principles that are socially shared and per sistent over time and that work symbolically to meaningfully structure the social world 183 . It is essential for scientists to understand this concept, because the inadequate com munication of information causes people to default to these frames. Framing has been defined as the process of selecting a few ele ments of a perceived reality and assembling a narrative that highlights connections among them to promote a particular interpreta tion for an individual 184 . We have already mentioned the misnomers that illustrate this concept. The term 'crack baby' evolved from social perceptions regarding individuals who use crack cocaine, the assumed severity of the impact of fetal exposure to an illegal drug, and a lack of understanding of the complex maternal status that included use of multiple drugs and malnutrition. The press and scientists alike were culpable in promoting this image in the absence of documented biological and behavioural effects. By the time science caught up, the frame had been cemented, and it remains an influential factor in defining public policy
.
Fully developed frames perform four functions: problem definition, causal analy sis, moral judgment and remedy promo tion 184, 185 . In order to provide more accurate information for policy makers the original concept must be reframed. Initially, the sci ence must be explained in such a way that it redirects attention away from the default positions. In part, redefining frames involves identifying values and explanations that make the societal, not individual, goals obvi ous. This can best be done by creating and using simplifying models to explain brain development, which in turn will assist in explaining the impact of drugs and stressors on the process. This provides an opportunity for science to explain how current policies surrounding drug use may have even more negative effects on the fetus than the drug itself, under certain circumstances. These models thus become vehicles through which science can positively influence policy thinking and decisions.
The Frameworks Institute has developed a frame of brain development that captures the essence of the scientific concept 186 . According to this frame, the early years of life matter because early experiences affect the architecture of the maturing brain. That architecture establishes either a sturdy or a fragile foundation for the development and behaviour that follow. Therefore, similar to building a house, getting things right the first time is easier than trying to fix them later 187 . This explanation of brain development reduces the complexity of the problem to a simple, concrete analogy that helps policy makers, members of the media and the pub lic organize information into a clear picture. Understanding that the assembly of brain architecture starts early, from the bottom up, paralleling the process of skill development in a child imparts a feel for the timedependent relationship between structure and function. This facilitates and stimulates interest in understanding the factors that can influence the process. For example, discussions of the more potent influence of alcohol and nico tine than cocaine on developing brain archi tecture lead directly to the conclusion that such exposures must also have more pro found functional consequences. This reduces the impact of the default frame (that illegal drugs are more detrimental to fetal develop ment than legal drugs). likewise, explana tions of the effect of 'toxic stress' -such as severe malnutrition -drug exposure, poor health care or lengthy incarceration on fetal brain architecture can lead to discussions between scientists and policy makers that evaluate the factors that may have the great est impact on child development 187 
There is thus an attainable goal of eliminating default frames and introducing more science based simplifying models that can alter the course of social and legal policies to best manage the difficulties of drug exposure during pregnancy
Looking to the future Scientists often find it bewildering that what seem to be basic concepts of develop ment are misrepresented or misinterpreted when policy decisions are being made. Policies are then established that are not based on the scientifically recognized fac tors that regulate development. Instead, policies reflect default frames of child development that typically focus on family, individual responsibility and safetyillegal equals 'more dangerous'; legal equals 'less dangerous' . Moreover, experts may unwittingly cross the line and move from being information providers to being advo cates. Science experts could thus be viewed as biased responders to queries from policy makers, moving beyond their area of expertise. So that science can inform the way that we, and other members of society, think about problems, scientific findings need to be shared with the community in such a way that we avoid loading information into default frames.
There are still significant questions that will require additional investigations.
For example, what are the consequences on fetal brain development of suspending drug treatment of a psychiatric disorder in a pregnant woman? Are there sensitive and critical periods of fetal brain develop ment that are more or less vulnerable to exposures of specific agents? Can we better define the biological interactions between multiple drug exposures, nutritional status and maternal stress that influence fetal brain development? Creating simple developmen tal models that clearly communicate these influences will be essential. Such models will assist policy makers in developing sound strategies for reducing the incidence of drug exposure during pregnancy and for implementing more effective treatments that maximize healthy development of the fetus when drug exposure during pregnancy does occur.
Box 3 | closing the gap -using what we know to inform what we do
Factors that influence maternal drug-abuse policy decisions:
• Public and media perception (including concepts such as free will, legality and excess)
• What science tells us (including information on maternal health, fetal-maternal interactions, and brain architecture and chemistry)
• Policy makers (influenced by public perception, legality and child welfare)
Strategies to affect public policy:
• Develop working partnerships (such as the National Conference of State Legislatures and childhood-focused private foundations)
• Engage scientists in providing impartial testimony ('what science tells us' and 'just the facts')
• Encourage scientists to work with video and print media to give the core story of the impact of drugs of abuse on fetal development
